在妇科恶性瘤中重新编程葡萄糖代谢
Jianhong Ma1, Zhiqiang Yao2, Liangjian Ma1
1The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, China.
Journal of Cancer
|April 5, 2024
概括
妇科瘤,包括宫癌,子宫内膜癌和卵巢癌,正在上升. 了解异常的葡萄糖代谢 (糖解) 是诊断和治疗这些癌症的关键.
科学领域:
- 在瘤学瘤学.
- 代谢研究研究 代谢研究
- 妇科 妇科医生 妇科
背景情况:
- 妇科瘤显示代谢活动增加,特别是在糖解中.
- 肥胖和病毒感染等因素导致癌症发病率上升.
- 瘤细胞糖解通过特定机制影响恶性行为.
研究的目的:
- 审查异常葡萄糖代谢和妇科瘤之间的联系.
- 阐明糖解蛋白质,分子和途径在瘤发生中的作用.
- 为早期查,诊断,治疗和复发预防提供见解.
主要方法:
- 关于葡萄糖代谢和妇科癌症的研究的文献综述.
- 分析糖解与子宫癌 (CC),子宫内膜癌 (EC) 和卵巢癌 (OC) 之间的相关性.
- 检查参与瘤代谢的信号通路和调节分子.
主要成果:
- 异常的葡萄糖代谢是CC,EC和OC的发展和进展的一个重要因素.
- 特定的糖溶性蛋白质和途径与恶性行为有关.
- 了解这些代谢变化提供了治疗目标.
结论:
- 针对异常的葡萄糖代谢是妇科癌症治疗的有希望的策略.
- 对瘤糖解的洞察力有助于开发早期检测和复发预防的干预措施.
- 对代谢途径的进一步研究可以改善妇科恶性瘤患者的治疗结果.
更多相关视频
相关概念视频
Hypoglycemia and Glucagon
257
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Overview of Carbohydrate Metabolism
994
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
994
Pathophysiology of Diabetes
926
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
926
Oral Hypoglycemic Agents: Biguanides and Glitazones
196
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
196


